Copyright © Inderes 2011 - present. All rights reserved.

Double Bond Pharmaceutical International

0.15 SEK

-6.99 %

Less than 1K followers

DBP B

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

-6.99 %
+41.67 %
+36.61 %
+42.33 %
-59.21 %
-68.68 %
-59.16 %
-91.80 %
-94.75 %

Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The company's business focus is on the treatment of cancer, infections and autoimmune diseases. The research is based on the company's proprietary drug-delivery technology. The products are sold under separate brands and product development collaborations take place with other players in the industry. The company is headquartered in Uppsala.

Read more
Market cap
31.48M SEK
Turnover
34.21K SEK
Revenue
1.09M
EBIT %
-711.93 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27/2
2026

Annual report '25

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.